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 James MacKenzie was a 19th century British general practitioner who became a pioneer in 
cardiovascular diagnosis and author of Symptoms and their Interpretation.  Mackenzie reflected: 
“Around 1883, I recognised that when the patients had some physical sign and when disease 
had made considerable ravages in the body, that a moderately accurate diagnosis could be 
made, but in the vast majority of my patients, there was no physical sign, or if there was a 
physical sign, I was not sure of its relationship to the patient’s ill health.”  Despite astounding 
advances in diagnostic technology, this observation holds true 130 years later. The key to 
effective care of most symptoms is not in the test but in the narrative.  
 Up to half of all outpatient visits are prompted by a physical/somatic complaint of which at 
least a third are medically unexplained symptoms (MUS) using the standard disease 
taxonomies offered by medical textbooks or ICD codes (Kroenke, 2014). Two articles in this 
issue provide important insights regarding the diagnosis and management of MUS. Analyzing 
data from the National Ambulatory Care Medical Survey, Gates et al confirmed the common 
finding that depression and anxiety in patients presenting with somatic symptoms are under-
recognized (Gates, Petterson, Wingrove, Miller, & Klink, 2016). Only 1-4% of such patients 
received a diagnosis of depression or anxiety, a rate that should have been at least 4- to 6-
folder greater. Moreover, less than 2% had documented screening for depression. Surprisingly, 
no primary care discipline outperformed the others which is counter to the conventional wisdom 
that a biopsychosocially-oriented discipline like family medicine should do better than more 
biomedically-inclined fields like internal medicine and obstetrics-gynecology.  
 Drawing upon clinical experience spanning several decades and thousands of patients, 
Clarke delineates a pragmatic approach to managing MUS (Clarke, 2016). His 6-step strategy 
augmented by illustrative cases makes more tangible the process of caring for patients with 
chronic symptoms. Besides MUS being a low priority for research funding and a curricular 
orphan in terms of medical training, several other barriers impede optimal care. Although Clarke 
suggests the information gleaned from his 6-step approach can be “gathered over several 
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appointments”, the exploration of illness chronology, adverse childhood experiences, and 
current psychosocial stresses and disorders is typically a gradual unfolding rather than a 
sudden epiphany, especially when these often painful pieces must be reassembled in a 
coherent and explanatory fashion for the patient. Time-limited visits in primary care combined 
with the competing demands of other medical disorders, preventive medicine, and 
documentation do not easily lend themselves to a longitudinal evaluation of complex MUS. 
Partnering with a mental health specialist is one solution, although only a minority of such 
specialists have either the interest or expertise to manage MUS and functional somatic 
syndromes. Moreover, these conditions reside at the interface of medical and mental health 
care and contend with coding and reimbursement policies as well as mental health carve-outs. 
 Despite these barriers, four themes can be extracted from these two articles as well as 
previous research to optimize the care of chronic somatic symptoms. 
1. Naming the Symptom 
 Whereas Clarke uses the term psychophysiological disorder, others have used terms like 
somatization, MUS, somatoform disorder, functional somatic syndrome, and bodily distress 
disorder. The lack of consensus on a single name stems from an imperfect causal 
understanding as well as the stigma that eventually accrues to labels for illnesses that clinicians 
find difficult or frustrating to treat (Kroenke,2001a).  For example, chronic fatigue syndrome 
(CFS) has also been called myalgic encephalitis, chronic fatigue and immune dysfunction 
syndrome and, more recently, systemic exertion intolerance disorder. These competing labels 
originate not out of any new evidence about disease mechanism but partly because CFS 
patients’ concerns are “often met with dismay and skepticism, if not outright dismissal” (Clayton, 
2015). For similar reasons, DSM-IV diagnoses like hypochrondriasis and somatoform disorders 
which had acquired a pejorative connotation were reframed in DSM-V as illness anxiety disorder 
and somatic symptom disorder, respectively. In a provocative study, 86 neurology patients were 
3 
 
asked about the negative connotations associated with different diagnoses for leg weakness: 
medically unexplained and psychosomatic were the most offensive labels; functional, stress-
related and depression were intermediate; and organic diagnoses like stroke and multiple 
sclerosis were the most acceptable (Stone et al., 2002).  In summary, it is probably alright to 
provide tentative disease labels which are more acceptable to patients and for which there may 
be preliminary evidence implying potential mechanisms. However, all such labels are 
placeholders until research better untangles complex symptoms and are at risk of becoming 
stigmatic terms until clinicians feel more empowered to treat these symptoms. 
2. Bridging the Divide 
 The strong relationship between physical and psychological symptoms is well-established. 
However, persuading the patient of this connection can be a delicate endeavor, especially as 
the destigmatization of mental disorders remains a work in progress. Reattributing somatic 
symptoms to psychological factors may backfire if foisted on patients prematurely without 
enabling them to discover it in their own illness narrative. Interestingly, qualitative analysis of 
physician-patient encounters reveal that patients frequently offer psychological cues which 
doctors ignore (Salmon, Dowrick, Ring, & Humphris, 2004). Moreover, the high co-occurrence 
of psychological and somatic symptoms could be causal, consequential, co-directional 
(reciprocal), or by-products of a common pathway. For example, depression may predispose to 
chronic pain, be a result of chronic pain, share a common biological pathway with pain, or be in 
a reciprocal relationship with pain; there is evidence for all four mechanisms, and some patients 
find the last 3 explanations more acceptable than the first. Having a low threshold for 
depression and anxiety screening is not only germane to MUS and functional syndromes but 
also for disease-specific somatic symptoms in patients with medical disorders for whom 
standard treatments fail to ameliorate the symptoms (Katon, Lin, & Kroenke, 2007). Brief 
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screeners for depression, anxiety and somatization are available (e.g., www.phqscreeners.com) 
and are useful for assessing severity and monitoring treatment. 
3. Solving the Case 
 Recent evidence-based reviews reveal 4 findings salient to the diagnostic evaluation of 
somatic symptoms (Kroenke, 2014; Rolfe & Burton, 2013). First, more than 75% of diagnostic 
information related to somatic symptoms resides in the history, with many fewer diagnoses 
dependent upon the physical examination, laboratory testing, imaging or other procedures. 
Second, up to 80% of patients improve within 2 weeks to a few months after their index visit to 
primary care for a somatic complaint. Third, serious occult diagnoses not apparent after initial 
evaluation seldom emerge in long-term follow-up across a variety of common symptoms. 
Fourth, testing in patients with a low-probability of disease results in far more false positive than 
true positive results and is not particularly effective in reassuring patients. Thus, a history and 
physical examination relevant to the somatic symptom coupled with clinical follow-up is 
preferable to an initial expensive work-up; in the absence of red flags indicative of a potentially 
serious disease, testing can generally be reserved for patients with persistent symptoms. 
4. Managing the Consequences 
 Several principles inform the management of somatic symptoms (Kroenke, 2014). First, 
multiple symptoms are the norm rather than the exception.  In 2 studies totaling 1500 primary 
care patients who completed a checklist of 15 common symptoms, the proportion who endorsed 
0-1, 2-3, 4-5, 6-8, and 9 or more symptoms was 21%, 23%, 21%, 22%, and 12%. The SPADE 
pentad (sleep-pain-anxiety-depression-energy/fatigue) is a particularly common cluster and 
most patients who have one of these symptoms have at least 2 to 3 of the others. Thus, while 
patients may present with one symptom, others commonly lurk in the background. Second, 
some treatments are effective across multiple types of physical symptoms and functional 
somatic syndromes, including cognitive-behavioral therapy, exercise, antidepressants, and 
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training physicians in managing MUS. Third, hybrid treatments that combine somatic and 
behavioral therapies may be warranted. Clarke describes a patient with stress-related 
abdominal pain who was “discharged with analgesic tablets and a plan to take regular time 
focused on personal enjoyment.” This is similar to medical conditions like diabetes which benefit 
from pharmacotherapy as well as diet, exercise and other lifestyle changes. Fourth, patient 
preferences should be elicited. Since both medication and nonpharmacological treatments are 
effective for symptoms like depression, anxiety, pain, and functional syndromes, shared 
decision-making regarding therapy is desirable. Fifth, since MUS are ubiquitous across all 
medical, surgical, and mental health specialties, the responsibility for effective communication 
with patients and symptom management should be distributed across all health care providers 
rather than relegated solely to primary care clinicians. 
 Chronic symptoms cause far more morbidity than mortality. As a consequence, however, 
they are especially disabling and costly. Pain conditions alone result in more years lived with 
disability than the top 12 medical diseases combined (US Burden of Disease Collaborators, 
2013). Yet the clinical attention these symptoms receive is not proportional to their public health 
burden. Even while we wait for research funding to become commensurate with the problem, 
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